The recent unveiling of the Sefia manufacturing platform by Cytiva, in partnership with Gilead Sciences’ Kite Pharma, marks a transformative step in the field of CAR-T cell therapy. With demand for these life-saving treatments increasing, the traditional production methods, fraught with manual
The seamless integration of technology into the fabric of scientific research has brought about a seminal shift in the analytical instrument industry. Key industry players have long recognized that innovation is not just a buzzword but the fundamental driver of growth and efficiency in the lab.
The financial markets have recently witnessed a significant uptick, particularly focusing on the robust performance of the S&P 500 index. With a history of early gains often translating into positive year-end outcomes, the current rise of over 10% within the first 100 trading days has set a hopeful
In the ever-evolving landscape of medical treatments, cell therapy emerges as a vivid illustration of how cutting-edge science can unlock new horizons in healthcare. This article delves into the transformative world of cell therapy, highlighting its current state, potential, and the multifaceted
The biotech industry is at a crossroads, grappling with the challenges and expectations set by cell therapies. Oncology-focused treatments that once held great promise are now facing a reality check, prompting many companies to reevaluate their focus on autoimmune diseases. As expectations align
In a significant expansion of its life sciences portfolio, global science and technology leader Merck has announced a definitive agreement to purchase Mirus Bio for a staggering $600 million. Mirus Bio, a pioneering life sciences company, specializes in developing transfection reagents, a
